Masimo

Masimo Revenue

Delisted

The The revenue of Masimo (MASI) as of Nov 22, 2026 is 1.53 B USD. In the previous year, The revenue was 2.09 B USD — a change of -27.10% (lower).

Revenue

1.53 BUSD

YoY

-27.10%

Last updated:

In 2025, Masimo's sales reached 1.53 B USD, a -27.10% difference from the 2.09 B USD sales recorded in the previous year.

Over the last 19 years Masimo grew revenue by 10.6% annually, reaching 1.53 B USD.

The Masimo Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2022
2.04 B USD
Jan 1, 2023
2.05 B USD
Jan 1, 2024
2.09 B USD
Jan 1, 2025
1.53 B USD
Jan 1, 2026 (e)
1.63 B USD
Jan 1, 2027 (e)
1.75 B USD
Jan 1, 2028 (e)
1.89 B USD
Jan 1, 2029 (e)
1.97 B USD
The Masimo Revenue history
YEARRevenueYoY
est1.97 BUSD+4.61%
est1.89 BUSD+7.93%
est1.75 BUSD+7.12%
est1.63 BUSD+6.92%
1.53 BUSD-27.10%
2.09 BUSD+2.26%
2.05 BUSD+0.60%
2.04 BUSD+64.28%
1.24 BUSD+8.35%
1.14 BUSD+21.95%
937.84 MUSD+9.27%
858.29 MUSD+8.61%
790.25 MUSD+10.85%
712.90 MUSD+13.14%
630.11 MUSD+7.41%
586.64 MUSD+7.20%
547.25 MUSD+10.95%
493.23 MUSD+12.36%
438.99 MUSD+8.28%
405.41 MUSD+16.12%
349.12 MUSD+13.69%
307.07 MUSD+19.82%
256.29 MUSD+14.24%
224.34 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Masimo Revenue

Masimo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
2.04 B USD
210.00 M USD
143.50 M USD
Jan 1, 2023
2.05 B USD
138.40 M USD
81.50 M USD
Jan 1, 2024
2.09 B USD
-261.70 M USD
-304.90 M USD
Jan 1, 2025
1.53 B USD
312.80 M USD
-151.50 M USD
Jan 1, 2026 (e)
1.63 B USD
498.99 M USD
323.74 M USD
Jan 1, 2027 (e)
1.75 B USD
557.22 M USD
358.94 M USD
Jan 1, 2028 (e)
1.89 B USD
617.50 M USD
398.32 M USD
Jan 1, 2029 (e)
1.97 B USD
617.25 M USD
398.25 M USD

Masimo Margins

Masimo stock margins

The Masimo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Masimo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Masimo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
52.01 %
10.32 %
7.05 %
Jan 1, 2023
49.00 %
6.76 %
3.98 %
Jan 1, 2024
47.96 %
-12.50 %
-14.56 %
Jan 1, 2025
61.90 %
20.49 %
-9.92 %
Jan 1, 2026 (e)
61.90 %
30.56 %
19.83 %
Jan 1, 2027 (e)
61.90 %
31.86 %
20.53 %
Jan 1, 2028 (e)
61.90 %
32.71 %
21.10 %
Jan 1, 2029 (e)
61.90 %
31.26 %
20.17 %

Masimo Stock analysis

What does Masimo do? Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Masimo's Sales Figures

The sales figures of Masimo originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Masimo’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Masimo's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Masimo’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Masimo stock

The revenue of Masimo is 1.53 B USD in 2025.

The revenue of Masimo changed from 2.09 B USD to 1.53 B USD, representing a -27.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The revenue Masimo since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Masimo historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Masimo

All Key Metrics — Masimo